RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 108 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $60,000 | -42.9% | 10,931 | +0.5% | 0.00% | -100.0% |
| Q4 2021 | $105,000 | -46.4% | 10,873 | -0.7% | 0.00% | -50.0% |
| Q3 2021 | $196,000 | -19.0% | 10,948 | +10.3% | 0.00% | 0.0% |
| Q2 2021 | $242,000 | -3.2% | 9,930 | +5.4% | 0.00% | 0.0% |
| Q1 2021 | $250,000 | – | 9,423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |